Research
Faculty
Name | Areas of Special Interest |
Coleen K. Cunningham, MD, Chief | Treatment of pediatric HIV, prevention of perinatal HIV transmission, and HIV vaccine studies |
| Daniel Benjamin, MD, MPH, PhD | Multicenter pediatric anti-infective trials, neonatal infections |
| Ann Buchanan, MD, MPH | Basic research in HIV-infected children and the opportunistic infections they acquire |
| Pediatric vaccine trials |
| Michael Cohen-Wolkowiez, MD | Safety, efficacy and pharmacokinetics of antimicrobials in infants |
| General infectious diseases, medical education |
| Harmony Garges, MD | Consulting Associate |
| Ravi R. Jhaveri, MD | Basic pathogenesis of hepatitis C, clinical outcomes of hepatitis C infection |
| Paul M. Lantos, MD | Tropical and parasitic diseases, mosquito and tick-borne infections, and travel medicine, pediatric and adolescent HIV/AIDS |
| Kathleen A. McGann, MD | Treatment of HIV infection in children, medical education |
| Clinical research in treatment of Pediatric HIV infection |
| M. Anthony Moody, MD | Study and design of HIV-1 and influenza vaccines, development of novel adjuvants, response of the humoral immune system to vaccination and infection |
| Sallie Permar, MD, PhD | Clinical research in HIV and CMV transmission, especially in breastfeeding. |
| Patrick C. Seed, MD, PhD | Molecular and cellular determinants of uropathogenic E. coli infection |
| Joseph St. Geme, III, MD | Haemophilus influenzae pathogenesis and vaccine development |
| William J. Steinbach, MD | Clinical and basic research in invasive fungal infections, with primary interest in Aspergillus pathogenesis |
| Emmanuel B. Walter, MD | Vaccine research in the Pediatric Primary Care Division, pediatric travel, international adoption |
| Samuel L. Katz, MD, emeritus | Pediatric vaccines, vaccine delivery in low resource settings |
| Catherine Wilfert, MD, emeritus | Treatment of HIV-infected children, prevention of mother to child HIV transmission in resource limited settings |
Research Staff
| Lab of Sallie Permar, MD, PhD |
Name | Areas of Special Interest
|
| Josh Amos | Research Analyst with expertise and interest in analysis of virus-specific B and T cell responses elicited during vaccination and infection in both human and nonhuman primate studies |
| Genevieve Fouda | Post-doctoral Fellow with expertise and interest in assessing the role of pathogen-specific antibody responses relevant to the setting of mother to child transmission |
| Tatenda Mahlokozera | Research Technician with interest and expertise in studying the virologic and immunologic factors associated with postnatal HIV transmission |
| Lab of Patrick Seed, MD, PhD |
Name | Areas of Special Interest |
| Zarine Balsara, MD, PhD | Resident in Urology studying the pathogenesis of urinary tract infection with spinal cord disability and the development of non-antibiotic prophylaxis to prevent the development of recurrent UTI |
| Stacey Prow Bateman | Graduate student in the Department of Molecular Genetics and Microbiology studying the role of the Fim recombinases in the epigenetic regulation of E. coli virulence during urinary tract infection and the role of the PAI-X genomic island in E. coli pathogenicity |
Carolos Goller, PhD | Post-doctoral Associate elucidating the function of the sialic acid regulator NanR as a regulator of E. coli virulence during UTI and using chemical genetics to identify inhibitors of polysaccharide capsule biogenesis and consequences of inhibition on E. coli UTI |
Mariam Susan LaTuga, MD | Clinical Fellow in Neonatology conducting research to understand the development of the gut-associated microbiome in very low birth weight babies |
| Akul Patel | Undergraduate student elucidating the DNA binding specificity of HyxR, a LuxR-family transcriptional regulator of the E. coli pathogenicity island PAI-X. |
| Tiffany Prest | Graduate student in the Department of Molecular Genetics and Microbiology conducting research to elucidate the role of polysaccharde capsule in intracellular replication of E. coli during urinary tract infection and the role of sialic acid as a regulator of E. coli virulence in vivo |
| Carla Ransom, MD | Clinical Fellow in Maternal-Fetal Medicine studying the mechanisms of adherence of Ureaplasma parvum to the fetal membranes and the role of U. parvum in preterm labor and premature rupture of membranes |
|
Lab of William Steinbach, MD
|
Name | Areas of Special Interest
|
| Jarrod Fortwendel, PhD | Post-doctoral Associate conducting research on Aspergillus fumigates pathogenesis |
| Praveen Juvvadi, PhD | Senior Research Associate conducting research on Aspergillus fumigates pathogenesis |
Clinical Research
- Evaluation of mother-to-child transmission of HIV
- Treatment of HIV and co-infections
- Evaluation of HIV vaccines in domestic as well as international settings
- Development and testing of candidate Tb and HIV vaccines
- Virulence factors in Hepatitis C
Basic Research
Bacterial Pathogenesis
- Haemophilus influenzae pathogenesis and vaccine development
- Molecular and cellular determinants of uropathogenic E. coli infection
Fungal Pathogenesis
- Evaluation of the pathogenic mechanisms of Aspergillus infection.
Clinical Trials
Clinical Trials have an important role in the improvement of health care for children; therefore, we consider it important to educate all patients about clinical trials. All children eligible for enrollment into a clinical trial will have that trial discussed with the parents or guardian and, when appropriate, with the patient. There are a large number of ongoing clinical trials in the areas of HIV treatment, prevention and long-term complications. In addition, there are ongoing trials of anti-HSV medications, anti-fungal medications and other clinical trials.